Cargando…

ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status

BACKGROUND: Corticotrophs are a well-known tissue susceptible to cytotoxicity by lymphocytes, as seen in autoimmune hypophysitis, suggesting that immunological approach may be one of the therapeutic strategies for ACTH-producing adenomas. However, the efficacy of immune therapy for general ACTH-prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuoka, Hidenoi, Itoh, Tomoo, Kanie, Keitaro, Kanzawa, Maki, Ogawa, Wataru, Shichi, Hiroki, Yamada, Shozo, Yamamoto, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625715/
http://dx.doi.org/10.1210/jendso/bvac150.1064
_version_ 1784822569688367104
author Fukuoka, Hidenoi
Itoh, Tomoo
Kanie, Keitaro
Kanzawa, Maki
Ogawa, Wataru
Shichi, Hiroki
Yamada, Shozo
Yamamoto, Masaaki
author_facet Fukuoka, Hidenoi
Itoh, Tomoo
Kanie, Keitaro
Kanzawa, Maki
Ogawa, Wataru
Shichi, Hiroki
Yamada, Shozo
Yamamoto, Masaaki
author_sort Fukuoka, Hidenoi
collection PubMed
description BACKGROUND: Corticotrophs are a well-known tissue susceptible to cytotoxicity by lymphocytes, as seen in autoimmune hypophysitis, suggesting that immunological approach may be one of the therapeutic strategies for ACTH-producing adenomas. However, the efficacy of immune therapy for general ACTH-producing adenomas remains unclear. And cortisol levels expected to affect the tumor microenvironment (TME). OBJECTIVES: To clarify whether ACTH-producing adenomas are sensitive to immunotherapy and if this approach can be a potential treatment for these challenging tumors. METHODS: TME was examined by immunostaining using pituitary adenomas specimens. This study consists of two phases: In phase 1, TME of ACTH-producing adenomas (n=29) was analyzed by comparing with GH-producing pituitary adenomas (GHomas) (n=10) and nonfunctioning pituitary adenomas (NPAs) derived from gonadotrophs origin (Gnomas) (n=10). In phase 2, corticotroph adenomas were divided into three groups that were considered to be at different cortisol exposure; naïve ACTH-producing adenomas (Naïve, n=29), treatment with metyrapone (Met, n=13), and silent corticotroph adenomas (SCAs) (n=12). These TME were analyzed and compared. To detect T-lymphocytes and M2 macrophages, antibodies to CD3, 4, or 8, and CD163 were used, respectively. The association between TME and patients’ background data including urinary free cortisol levels were analyzed. RESULTS: Phase 1: Tumor infiltrating lymphocytes (TILs) evaluated by CD3 + cells inACTH-producing adenomas were less than those in the GHomas (p<0. 01) and lower tendency compare to Gnomas (p=0. 05). Among them, CD8 + cells in ACTH-producing adenomas were less than both (p<0. 01, p<0. 01, respectively). CD163 + cells were widely distributed in ACTH-producing adenomas but less than Gnomas (p<0. 01). The number of CD163 + cells were not associated with tumor aggressiveness or invasiveness in ACTH-producing adenomas. Phase 2: First, SCAs, NPAs from corticotroph origin were compared to Gnomas, showing that less CD8 + cells were detected in SCAs (p<0. 01), suggesting low CD8 + cells were common feature of corticotroph adenomas regardless of cortisol level. Among 3 groups of different cortisol exposure, CD4 + cells were higher both in Met and SCAs than in Naïve (p<0. 01, p=0. 01, respectively), while CD8+ cells were not altered. In contrast, the number of CD163+ cells were lower in Met than Naïve (p<0. 01), suggesting the association between cortisol levels and the number of CD163 + cells. CONCLUSIONS: We revealed for the first time that low TILs are common features among corticotroph adenomas regardless cortisol levels. Moreover, the CD4 + cells but not CD8 + cells were higher in tumors with low cortisol status, suggesting induction of CD8 + cells are required for the immune therapy to corticotroph adenomas. Regarding with CD163 + cells, no association with tumor behavior was shown rather related to cortisol exposure status. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9625715
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96257152022-11-14 ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status Fukuoka, Hidenoi Itoh, Tomoo Kanie, Keitaro Kanzawa, Maki Ogawa, Wataru Shichi, Hiroki Yamada, Shozo Yamamoto, Masaaki J Endocr Soc Neuroendocrinology and Pituitary BACKGROUND: Corticotrophs are a well-known tissue susceptible to cytotoxicity by lymphocytes, as seen in autoimmune hypophysitis, suggesting that immunological approach may be one of the therapeutic strategies for ACTH-producing adenomas. However, the efficacy of immune therapy for general ACTH-producing adenomas remains unclear. And cortisol levels expected to affect the tumor microenvironment (TME). OBJECTIVES: To clarify whether ACTH-producing adenomas are sensitive to immunotherapy and if this approach can be a potential treatment for these challenging tumors. METHODS: TME was examined by immunostaining using pituitary adenomas specimens. This study consists of two phases: In phase 1, TME of ACTH-producing adenomas (n=29) was analyzed by comparing with GH-producing pituitary adenomas (GHomas) (n=10) and nonfunctioning pituitary adenomas (NPAs) derived from gonadotrophs origin (Gnomas) (n=10). In phase 2, corticotroph adenomas were divided into three groups that were considered to be at different cortisol exposure; naïve ACTH-producing adenomas (Naïve, n=29), treatment with metyrapone (Met, n=13), and silent corticotroph adenomas (SCAs) (n=12). These TME were analyzed and compared. To detect T-lymphocytes and M2 macrophages, antibodies to CD3, 4, or 8, and CD163 were used, respectively. The association between TME and patients’ background data including urinary free cortisol levels were analyzed. RESULTS: Phase 1: Tumor infiltrating lymphocytes (TILs) evaluated by CD3 + cells inACTH-producing adenomas were less than those in the GHomas (p<0. 01) and lower tendency compare to Gnomas (p=0. 05). Among them, CD8 + cells in ACTH-producing adenomas were less than both (p<0. 01, p<0. 01, respectively). CD163 + cells were widely distributed in ACTH-producing adenomas but less than Gnomas (p<0. 01). The number of CD163 + cells were not associated with tumor aggressiveness or invasiveness in ACTH-producing adenomas. Phase 2: First, SCAs, NPAs from corticotroph origin were compared to Gnomas, showing that less CD8 + cells were detected in SCAs (p<0. 01), suggesting low CD8 + cells were common feature of corticotroph adenomas regardless of cortisol level. Among 3 groups of different cortisol exposure, CD4 + cells were higher both in Met and SCAs than in Naïve (p<0. 01, p=0. 01, respectively), while CD8+ cells were not altered. In contrast, the number of CD163+ cells were lower in Met than Naïve (p<0. 01), suggesting the association between cortisol levels and the number of CD163 + cells. CONCLUSIONS: We revealed for the first time that low TILs are common features among corticotroph adenomas regardless cortisol levels. Moreover, the CD4 + cells but not CD8 + cells were higher in tumors with low cortisol status, suggesting induction of CD8 + cells are required for the immune therapy to corticotroph adenomas. Regarding with CD163 + cells, no association with tumor behavior was shown rather related to cortisol exposure status. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625715/ http://dx.doi.org/10.1210/jendso/bvac150.1064 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Fukuoka, Hidenoi
Itoh, Tomoo
Kanie, Keitaro
Kanzawa, Maki
Ogawa, Wataru
Shichi, Hiroki
Yamada, Shozo
Yamamoto, Masaaki
ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title_full ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title_fullStr ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title_full_unstemmed ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title_short ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
title_sort odp355 the analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625715/
http://dx.doi.org/10.1210/jendso/bvac150.1064
work_keys_str_mv AT fukuokahidenoi odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT itohtomoo odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT kaniekeitaro odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT kanzawamaki odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT ogawawataru odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT shichihiroki odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT yamadashozo odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus
AT yamamotomasaaki odp355theanalysisoftumorinfiltrativelymphocytesincorticotrophadenomasanditsrelationtohormonalstatus